PharmaVision's Diagnostic and Imaging reports provide in-depth coverage of in vitro and in vivo diagnostic modalities and recent scientific and technological advances in point-of-care testing to optimize screening, diagnosis, prognosis, treatment and surgical intervention and to reduce the healthcare burden of prevalent diseases. Increasingly, the pharmaceutical industry is utilising diagnostics to guide pipeline projects and to support the prescription of market products through the development of companion diagnostics. Each report assesses the competitive landscape and analyses key market trends, diagnostic and imagining developments, and market leaders as well as assessing the impact of regulation and reimbursement on the uptake of diagnostics and the personalisation of treatment.